ArticleFrontiers in endocrinology2025

Atherogenic ApoB-dyslipidemia, atherosclerotic cardiovascular disease, cardiac dysfunction and remodeling in high-risk young women with and without polycystic ovary syndrome: A pilot study.

Xiaoying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.